Venlafaxine
General properties
Means acting on the nervous system. Psychoanaleptics. Antidepressants. Venlafaxine.
- Treatment of major depressive episodes.
- Prevention of recurrence of major depressive episodes.
Hypersensitivity to venlafaxine or to any component of the drug; Concomitant therapy with any MAOI inhibitors (reversible, irreversible, selective and non-selective); High risk of severe ventricular arrhythmia in the patient (for example, with significant left ventricular dysfunction of the heart of the III - IV functional class according to criteria of the New York Heart Association); Severe degree of arterial hypertension (blood pressure 180/115 mm Hg and higher before the start of therapy); Angle-closure glaucoma; Severe hepatic and / or renal insufficiency; Urination disorders due to insufficient urine outflow (eg, prostate disease).
Pharmaceutical characteristics
Single-layer tablets are round in shape, light yellow in color, the upper and lower surfaces are flat, the edges of the surfaces are beveled, with the risk for division from one side.
Store in the original packaging at a temperature not exceeding 25 °C. Keep out of the reach of children.
